The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
pH‐ and NIR Light‐Responsive Micelles with Hyperthermia‐Triggered Tumor Penetration and Cytoplasm Drug Release to Reverse Doxorubicin Resistance in Breast Cancer
Abstract
The acquisition of multidrug resistance (MDR) is a major hurdle for the successful chemotherapy of tumors. Herein, a novel hybrid micelle with pH and near‐infrared (NIR) light dual‐responsive property is reported for reversing doxorubicin (DOX) resistance in breast cancer. The hybrid micelles are designed to integrate the pH‐ and NIR light‐responsive property of an amphiphilic diblock polymer and the high DOX loading capacity of a polymeric prodrug into one single nanocomposite. At physiological condition (i.e., pH 7.4), the micelles form compact nanostructure with particle size around 30 nm to facilitate blood circulation and passive tumor targeting. Meanwhile, the micelles are quickly dissociated in weakly acidic environment (i.e., pH ≤ 6.2) to release DOX prodrug. When exposed to NIR laser irradiation, the hybrid micelles can trigger notable tumor penetration and cytosol release of DOX payload by inducing tunable hyperthermia effect. In combination with localized NIR laser irradiation, the hybrid micelles significantly inhibit the growth of DOX‐resistant MCF‐7/ADR breast cancer in an orthotopic tumor bearing mouse model. Taken together, this pH and NIR light‐responsive micelles with hyperthermia‐triggered tumor penetration and cytoplasm drug release can be an effective nanoplatform to combat cancer MDR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Dysregulated pH: a perfect storm for cancer progression
Webb, B. A., Chimenti, M., Jacobson, M. P., & Barber, D. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3110 · Cited by 2,237
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy
Doane, T. L., & Burda, C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15260f · Cited by 1,098
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Wong, C., Stylianopoulos, T., Cui, J., Martin, J., Chauhan, V. P., Jiang, W., Popović, Z., Jain, R. K., Bawendi, M. G., & Fukumura, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018382108 · Cited by 1,062
Size‐Dependent Endocytosis of Nanoparticles
Zhang, S., Li, J., Lykotrafitis, G., Bao, G., & Suresh, S. (2009) · Advanced Materials · doi:10.1002/adma.200801393 · Cited by 1,059
Ashley, C. E., Carnes, E. C., Phillips, G. K., Padilla, D., Durfee, P. N., Brown, P. A., Hanna, T. N., Liu, J., Phillips, B., Carter, M. B., et al. (2011) · Nature Materials · doi:10.1038/nmat2992 · Cited by 1,024
Ernsting, M. J., Murakami, M., Roy, A., & Li, S.-D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.013 · Cited by 1,012
Chen, A. M., Zhang, M., Wei, D., Stueber, D., Taratula, O., Minko, T., & He, H. (2009) · Small · doi:10.1002/smll.200900621 · Cited by 671
Xiong, X.-B., & Lavasanifar, A. (2011) · ACS Nano · doi:10.1021/nn2013707 · Cited by 411
Stimuli‐Responsive Materials for Controlled Release of Theranostic Agents
Wang, Y., Shim, M. S., Levinson, N. S., Sung, H., & Xia, Y. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201400279 · Cited by 378
Integration of Nanoassembly Functions for an Effective Delivery Cascade for Cancer Drugs
Sun, Q., Sun, X., Ma, X., Zhou, Z., Jin, E., Zhang, B., Shen, Y., Van Kirk, E. A., Murdoch, W. J., Lott, J. R., et al. (2014) · Advanced Materials · doi:10.1002/adma.201401554 · Cited by 377
Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
Yin, Q., Shen, J., Zhang, Z., Yu, H., & Li, Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.04.011 · Cited by 365
Self-citationPolymer conjugates with anticancer activity
Putnam, D., & Kopeček, J. (1995) · Advances in Polymer Science · doi:10.1007/3540587888_14 · Cited by 315
Prodrug-based intracellular delivery of anticancer agents
Bildstein, L., Dubernet, C., & Couvreur, P. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.005 · Cited by 310
Batrakova, E. V., Li, S., Vinogradov, S. V., Alakhov, V. Y., Miller, D. W., & Kabanov, A. V. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29254-5 · Cited by 292
Batrakova, E., Lee, S., Li, S., Venne, A., Alakhov, V., & Kabanov, A. (1999) · Pharmaceutical Research · doi:10.1023/a:1018942823676 · Cited by 289
Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
Calcagno, A. M., Salcido, C. D., Gillet, J.-P., Wu, C.-P., Fostel, J. M., Mumau, M. D., Gottesman, M. M., Varticovski, L., & Ambudkar, S. V. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq361 · Cited by 279
Schindler, M., Grabski, S., Hoff, E., & Simon, S. M. (1996) · Biochemistry · doi:10.1021/bi952234e · Cited by 269
Tumor Acidity, Chemoresistance and Proton Pump Inhibitors
De Milito, A., & Fais, S. (2005) · Future Oncology · doi:10.2217/14796694.1.6.779 · Cited by 265
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Kirtane, A. R., Kalscheuer, S. M., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 258
Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis
Liang, X.-J., Meng, H., Wang, Y., He, H., Meng, J., Lu, J., Wang, P. C., Zhao, Y., Gao, X., Sun, B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909707107 · Cited by 256
Yu, H., Zou, Y., Wang, Y., Huang, X., Huang, G., Sumer, B. D., Boothman, D. A., & Gao, J. (2011) · ACS Nano · doi:10.1021/nn203503h · Cited by 238
Self-citationPhotoswitchable nanoparticles for in vivo cancer chemotherapy
Tong, R., Chiang, H. H., & Kohane, D. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315336110 · Cited by 227
Therapeutic Nanoparticles to Combat Cancer Drug Resistance
Hu, C.-M., & Zhang, L. (2009) · Current Drug Metabolism · doi:10.2174/138920009790274540 · Cited by 223
Soppimath, K. S., Liu, L. ‐., Seow, W. Y., Liu, S. ‐., Powell, R., Chan, P., & Yang, Y. Y. (2007) · Advanced Functional Materials · doi:10.1002/adfm.200500611 · Cited by 188
Wang, L., Lin, X., Wang, J., Hu, Z., Ji, Y., Hou, S., Zhao, Y., Wu, X., & Chen, C. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201400015 · Cited by 156
Guo, M., Huang, J., Deng, Y., Shen, H., Ma, Y., Zhang, M., Zhu, A., Li, Y., He, H., Wang, Y., et al. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201402762 · Cited by 136
Self-citationGuided delivery of polymer therapeutics using plasmonic photothermal therapy
Gormley, A. J., Larson, N., Sadekar, S., Robinson, R., Ray, A., & Ghandehari, H. (2012) · Nano Today · doi:10.1016/j.nantod.2012.04.002 · Cited by 119
Hershman, D. L., Tsui, J., Meyer, J., Glied, S., Hillyer, G. C., Wright, J. D., & Neugut, A. I. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju319 · Cited by 106
Synthesis and Characterization of a Macrocyclic Near-Infrared Optical Scaffold
Ye, Y., Li, W. P., Anderson, C. J., Kao, J., Nikiforovich, G. V., & Achilefu, S. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034186o · Cited by 71
Yu, H., Zou, Y., Jiang, L., Yin, Q., He, X., Chen, L., Zhang, Z., Gu, W., & Li, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.042 · Cited by 71
Self-citationYu, H., Xu, Z., Chen, X., Xu, L., Yin, Q., Zhang, Z., & Li, Y. (2013) · Macromolecular Bioscience · doi:10.1002/mabi.201300282 · Cited by 70
Self-citationIntracellular pH-activated PEG-b-PDPA wormlike micelles for hydrophobic drug delivery
Yu, H., Xu, Z., Wang, D., Chen, X., Zhang, Z., Yin, Q., & Li, Y. (2013) · Polymer Chemistry · doi:10.1039/c3py00849e · Cited by 61
Self-citationRole of organelle pH in tumor cell biology and drug resistance
Simon, S. M. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(98)01276-8 · Cited by 60
Fatemian, T., Othman, I., & Chowdhury, E. H. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.08.007 · Cited by 21
Adjuvant radiation therapy for breast cancer in patients with schizophrenia
Abdullah, K. N., Janardhan, R., Hwang, M. C., Williams, C. D., Farasatpour, M., Margenthaler, J. A., Virgo, K. S., & Johnson, F. E. (2014) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2014.07.004 · Cited by 14
Cited by
Chen, W., Ouyang, J., Liu, H., Chen, M., Zeng, K., Sheng, J., Liu, Z., Han, Y., Wang, L., Li, J., et al. (2017) · Advanced Materials · doi:10.1002/adma.201603864 · Cited by 1,027
Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals
Homayun, B., Lin, X., & Choi, H.-J. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030129 · Cited by 837
Current trends and challenges in cancer management and therapy using designer nanomaterials
Navya, P. N., Kaphle, A., Srinivas, S. P., Bhargava, S. K., Rotello, V. M., & Daima, H. K. (2019) · Nano Convergence · doi:10.1186/s40580-019-0193-2 · Cited by 672
pH-responsive polymer nanoparticles for drug delivery
Deirram, N., Zhang, C., Kermaniyan, S. S., Johnston, A. P. R., & Such, G. K. (2019) · Macromolecular Rapid Communications · doi:10.1002/marc.201800917 · Cited by 531
Mandal, A., Bisht, R., Rupenthal, I. D., & Mitra, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.012 · Cited by 481
Metadata
- Authors
- Yu, H., Cui, Z., Yu, P., Guo, C., Feng, B., Jiang, T., Wang, S., Yin, Q., Zhong, D., Yang, X., Zhang, Z., & Li, Y.
- Venue
- Advanced Functional Materials
- Publisher
- Wiley
- Published
- 2015-03-16
- Volume
- 25
- Issue
- 17
- Pages
- 2489-2500
- ISSN
- 1616-301X (ISSN-L)
- 1616-3028
- OpenAlex
- W2042769575
- Cited by
- 253
- References
- 42
- FWCI
- 13.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.